Drug
target validation
Vol.
422, No. 6929 (20 March 2003)
The route to new therapeutics often ends
in costly failure. The secret of success is the rapid and accurate identification
and validation of drug targets with true potential, says Caitlin Smith.
 | |||
 | |||
| Hitting
the target CAITLIN SMITH doi:10.1038/422341a
| 341 | | |
| |||
| A
question of form CAITLIN SMITH doi:10.1038/422341b
| 341 | | |
| |||
| The
silent treatment CAITLIN SMITH doi:10.1038/422343a
| 343 | | |
| |||
| A
whole picture CAITLIN SMITH doi:10.1038/422345a
| 345 | | |
| |||
| table
of suppliers doi:10.1038/422349a
| 349 | | |
